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Exercise-Induced Mitrai Regurgitation and 
Antibiotic Prophylaxis Against Infective 
Endocarditis in Mitral Valve Prolapse 
I read with great interest he results of the study by Stoddard et al. (1) 
dealing with exercise-induced mitral regurgitation as a predictor of 
morbid events in patients with mitral valve prolapse. Their observation 
raises the important question of which patients with mitral valve 
prolapse should receive antibiotic prophylaxis against infective endo- 
carditis. 
According to the American Heart Association guidelines (2), only 
those patients with mitral valve prolapse and valvular regurgitation 
need antibiotic prophylaxis against infective endocarditis. But how do 
we define mitral valvular regurgitation? Patients with mitral valve 
prolapse may not have mitral regurgitation at rest but develop it after 
exercise; exercise-induced mitral regurgitation occurred in as many as 
33% of the patients tudied by Stoddard et al (1). Many a patient at 
rest may exhibit a murmur due to mitral regurgitation on one occasion 
but not on another (3). Mitral regurgitation considerably increases thc 
risk of infective endocarditis (4,5). Infective endocarditis complicating 
mitral valve prolapse causes considerable cumulative morbidity and 
incremental health care costs (6), but antibiotic prophylaxis against 
infective ndocarditis i highly cost-effective (7). Therefore, should not 
all patients with mitral valve prolapse receive antibiotic prophylaxis 
whether or not mitral regurgitation is evident on routine physical 
examination? 
TSUNG O. CHENG, MD, FACC 
Department of Medicine 
George Washington Univer~in' Medical ( emer 
2150 Penn.9'h'ania Avenue, NW 
l+izshington, D.C. 20037 
References 
1. Smddard MF, Prince CR. [)ilion N. l,ongakcr RA. Morris G'F. Liddell NE. Exercise 
induced mitral regurgitation is apredictor I morbid events in subjects with mitral valve 
prolapse. J Am Coil Cardiul 1905:25:693 . 
2, Dajani AS, gisno AL, Chung KI, el al. Prevention f bactcriaI endocarditis. A statement for
health professionals from the Committee on Rheumatic Fever. Endocarditis, and Kawasaki 
Disease of the Council on Cardiovascular Disease in the Young, the American Heart 
Associatiun. Circulation 1991:83: I 174 - 8. 
3. Barlow JB, Cheng TO. Mitral valve billowing and prolapse. In: Cheng TO. (editor). The 
international Textbook of Cardiology. New York: Pergamon Press, 1987:4q7~24. 
4, Hickcy AJ, MacMahon SW, Wilcken DEL, Mitral valve prolapse and bacterial cndocar 
ditis: when is antibiotic prophylaxis necessary? Am Heart J 1985;109:431-5. 
5, MacMahon SW. Roberts JK. Kramer-Fox R, Zueker DM, Roberts RB, Devereux RB. 
Mitral valve prolapse and infective endocarditis. Am Heart J 1987:113:1291-8. 
6. Frary C J, De,,'ercux RB, Kramer-Fox R.Roberts RB, Ruchlin tfS. Clinical and health care 
cost consequences of infective ndocarditis in mitral valve prolapse. ~m J Cardinl 
1994:73:263-7. 
7. Gould IM, Buckingham JK. ('t)st elfecti~eness nf prophylaxis in dental practice to pre~cnl 
infective cndnearditis. Br Heart J lt~93:71):7q-83 
R~ly 
We appreciate the very interesting question raised by Cheng concern- 
ing the potential need for antibiotic prophylaxis in all patients with 
documented mitral valve prolapse, given that mitral regurgitation in 
this condition may be transient and provoked by exercise (1). Althongh 
we cannot advocate the routine use of antibiotic prophylaxis in patients 
with mitral wtlve prolapse and no regurgitation during rest, we havc 
adopted this approach in the management of our patients with mitral 
valve prolapse. This approach is controversial, but we believe that it is 
supported by knowledge of the dynamic nature of mitral regurgitation 
in patients with mitral valve prolapse. However, it is possible that only 
patients with mitral valve prolapse with persistent compared with 
transient mitral regurgitation are at higher risk for endocarditis. The 
ultimate decision to use antibiotic prophylaxis in patients with mitral 
valve prolapse and no mitral regurgitation at rest must be made on an 
individual basis. Factors such as the nature of the invasive procedure, 
previous history of endocarditis and mitral valve redundancy may 
weigh heavily in the final decision to use or not to use antibiotic 
prophylaxis. Data from randomized clinical trials are lacking and are 
needed before definitive conclusions addressing the issue raised by 
Cheng can be reached. 
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International Comparisons of Waiting Times 
for Cardiovascular Procedures* 
As a Canadian clinical cardiologist, I read with interest he article by 
Carroll et al. ( 1 ) and the editorial comment by Ryan (2). I believe that 
the waiting times provided for Canadian catheterization laboratories 
and bypass surgery facilities are probably correct, and I agree that 
these waiting times are longer than they should be. My concern with 
the article, however, is whether it appropriately demonstrates the 
difference in access to cardiac care. Access is more than a matter of 
waiting time for operation, it is also a matter of whether one is 
considered worthy of being placed on the waiting list at all. 
In Canada. every patient who is considered a candidate for 
angiography is placed on the waiting list for angiography and subse- 
quently on the waiting list for bypass surgery. Whether the individual 
patient can afford to pay for bypass urgery is not a concern in Canada. 
My question is, How many patients who fit the profiles in the report by,. 
Carroll et al. do not get on the waiting list because they have n/oo 
insurance and cannot afford to pay for angiography or bypass surgery. 
I believe that it is better to have everyone wait somewhat longer rather 
than to provide a shorter waiting time for one group at the expense of 
no angiography or bypass surgery in the group with no money. 
I would be interested in a report that canvased cardiologists and 
primary' carc physicians, especially in some of the more economically 
disadvantaged regions, to determine how many U.S. patients do not 
make it onto the lists. Carroll et al. do quote an American Medical 
Association poll showing that the majority of Americans would prefer 
to spend more on health care and receive it quickly than wait longer for 
lower cost care. My question is, What about the Americans who cannot 
• The opinions expressed in this letter are those of the author and do not 
necessarily reflect those of the Department of National Defence, Canada. 
